CFO Presents Strategy to Deliver Growth and Vision for Future at Wells Fargo Healthcare Conference SUNNYVALE, Calif. , June 21, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the company's successes since its acquisition of
Advancements in Treatment Planning and Delivery Enable CyberKnife Centers to Fulfill Increasing Demand for Radiosurgery SUNNYVALE, Calif., Sept. 22 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Oklahoma CyberKnife
Robotic Radiosurgery System Provides Effective, Non-invasive Treatment Option for this Chronic Pain Condition, Typically Delivered in Just One Out-Patient Procedure SUNNYVALE, Calif. , Feb. 28, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the National Institute for
Technological Advancements Enable Highly-Complex Treatments to be Delivered in Routine Clinical Practice SUNNYVALE, Calif., Oct. 22 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that CyberKnife Centers of San Diego has
--CyberKnife Centers Are Meeting Increasing Demand for Radiosurgery Using Sophisticated Treatment Planning and Delivery Technologies SUNNYVALE, Calif., May 22, 2009 /PRNewswire-FirstCall via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced
Data Reinforce TomoTherapy System Mainstream Use, Benefits Including Improved Tumor Control and Reduced Toxicity SUNNYVALE, Calif. , July 14, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that studies on the clinical use of the TomoTherapy ® System continue to
SUNNYVALE, Calif. , May 30, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that recently published data from two new studies demonstrate the benefits of the TomoTherapy ® System in the delivery of total body irradiation (TBI), a procedure commonly used to prepare patients
SUNNYVALE, Calif. , Oct. 26, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved reimbursement for the CyberKnife ® System for the treatment of trigeminal neuralgia (TN).
Updated ASTRO Model Policy Endorses Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer SUNNYVALE, Calif. , May 21, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today the publication of study results involving hundreds of prostate cancer patients treated with the
Prospective, Multicenter Study Supported by the French National Institute of Cancer Also Demonstrates that Treatment with the TomoTherapy Platform Resulted in a Significantly Better Cancer-Specific Survival Rate and Post-Treatment Salivary Function SUNNYVALE, Calif.
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
